Breast Cancer Trial, Recruiting NCT07387445 Sponsor: University of Illinois at Chicago Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07387445
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 25 and 99 years old at the time of signing up
  • You speak English or Spanish (depending on interpreter availability at the study site)
  • You are generally able to carry out normal daily activities with little or no limitation (confirm with trial site)
  • You have been diagnosed with breast cancer confirmed by laboratory testing, either at an early to intermediate stage (Stage I–III), or at an advanced stage (Stage IV) with approval from your cancer doctor
  • Your blood counts and organ function meet certain minimum health levels, confirmed through a blood test
  • Your required lab tests have been done within 30 days before enrolling in the study
  • You are able to sign a consent form agreeing to take part and allowing your health information to be used for the study
  • If you could become pregnant, you must not currently be pregnant or breastfeeding, confirmed by a pregnancy test
  • You are able to understand and follow the study instructions for the full length of the study, as decided by the enrolling doctor

Who may not be able to join:

  • You have Type 1 diabetes or insulin-dependent Type 2 diabetes
  • Your body weight falls outside a certain healthy range (BMI above 45 or below 18.5) (confirm with trial site)
  • You are currently pregnant or breastfeeding
  • You work shift work (e.g., night shifts or rotating schedules)
  • You have a history of eating disorders
  • You have had a significant weight change (gained or lost more than about 9 pounds) in the 3 months before joining
  • You have uncontrolled HIV/AIDS or an active hepatitis infection
  • You have had another cancer diagnosis within the last 5 years, received chemotherapy within the last year, or have another current cancer that could affect the study results
  • Your breast cancer has come back, as determined by your cancer doctor
  • You have a mental or physical condition that prevents you from giving consent or taking part in the trial
  • You have another serious health condition, as decided by the study doctor
  • You have used illegal drugs in the past 3 months or regularly drink more than 2 alcoholic drinks per day
  • You are currently taking part in a weight loss program such as Weight Watchers, or taking weight loss medications (such as GLP-1 drugs like Ozempic or Wegovy)
  • You have had a heart attack
  • You have heart failure
  • You have chronic hepatitis
  • You have cirrhosis (scarring of the liver)
  • You have chronic pancreatitis (long-term inflammation of the pancreas)
  • You have had a solid organ transplant (such as a kidney, liver, or heart transplant)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment feasibility; TRE Acceptibility; TRE adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov